ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1613

Adherence to Dietary Recommendations and the Risk of Developing Giant Cell Arteritis; A Nested Case-Control Study

Poi Kwanyuen1, Karin Wadström1, Emily Sonestedt1, Charlotta Fors1, Rebecka Bäcklund1, Aladdin Mohammad2, Lennart TH Jacobsson1 and Carl Turesson1, 1Lund University, Malmö, Sweden, 2Lund University, Lund, Sweden

Meeting: ACR Convergence 2024

Keywords: diet, giant cell arteritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Giant cell arteritis (GCA) affects large and medium-sized vessels in elderly individuals. Previous studies have reported associations with lower body mass index and lower plasma glucose levels several years before diagnosis. The impact of diet on development of GCA has not been extensively investigated. The purpose of this study was to examine the relation between adherence to dietary recommendations, and quantified intake of the components of these recommendations, and the risk of developing GCA.

Methods: Participants in a population-based health survey who subsequently developed GCA were identified through register linkage and validated in a structured review. Four controls, matched for age, sex and year of inclusion in the survey, were selected for each case. Data on lifestyle, including diet, was collected using a questionnaire and diet history method, which included a 7-day food diary, a 168-item questionnaire and a 1-hour interview. Diet quality was assessed using the Swedish Dietary Guidelines Score (SDGS, range 0-5), which included adherence to recommendations on intakes of fiber, fruits and vegetables, fish and shellfish, red and processed meat, and added sugar. The relations for the SDGS, adherence to each component and total intake of each component with subsequent development of GCA were assessed using logistic regression analysis, including the case-control group as a categorical variable. The models were adjusted for total energy intake, leisure-time physical activity and alcohol intake. Potential misreporters of total energy intake were excluded from the adjusted models.

Results: There were 193 incident cases of GCA (78% women, mean age at diagnosis 75.4 years, 65% biopsy positive, mean time from inclusion in the health survey to GCA diagnosis 15.7 years). Demographics, adherence to dietary recommendations and reported total intake for each component of the SDGS for pre-GCA cases and controls are shown in Table 1. High adherence to dietary guidelines (SDGS 4-5 vs 0) was associated with subsequent development of GCA (adjusted odds ratio 2.70; 95% confidence interval 1.43-5.10). In adjusted models, adherence to recommended intake of added sugar (< 10% of energy intake), fish and shellfish ( >300 g/week) and vegetables and fruits ( >400 g/day) was associated with an increased risk of GCA (Table 2). A reduced risk was seen with higher quantified consumption of added sugar, and an increased risk with higher intakes of fiber and fish and shellfish (Table 3).

Conclusion: An overall high diet quality, with limited intake of added sugar, high intake of fiber and fish and shellfish, and recommended intake of vegetables and fruits, was independently associated with an increased risk of GCA. This is compatible with the concept of an increased risk of GCA in subjects with a healthy metabolic profile, and of metabolic regulation of early disease mechanisms in the development of GCA.

Supporting image 1

Table 1

Supporting image 2

Table 2

Supporting image 3

Table 3


Disclosures: P. Kwanyuen: None; K. Wadström: None; E. Sonestedt: None; C. Fors: None; R. Bäcklund: None; A. Mohammad: Abbvie, 2, AstraZeneca, 2, Boehringer Ingelheim, 2, GlaxoSmithKlein(GSK), 2, Vifor/CSL, 2; L. Jacobsson: AbbVie/Abbott, 1, 6, Eli Lilly, 1, Janssen, 1, 6, Novartis, 1, 6, UCB, 1; C. Turesson: AbbVie/Abbott, 1, 6, Boehringer-Ingelheim, 1, 6, Novartis, 6, Pfizer, 6.

To cite this abstract in AMA style:

Kwanyuen P, Wadström K, Sonestedt E, Fors C, Bäcklund R, Mohammad A, Jacobsson L, Turesson C. Adherence to Dietary Recommendations and the Risk of Developing Giant Cell Arteritis; A Nested Case-Control Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/adherence-to-dietary-recommendations-and-the-risk-of-developing-giant-cell-arteritis-a-nested-case-control-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adherence-to-dietary-recommendations-and-the-risk-of-developing-giant-cell-arteritis-a-nested-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology